Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Anti-Inflammatory Therapy in Asthma: Corticosteroids and Leukotriene Antagonists

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 3, 2010-09 ,pp. : 267-275

Bentham Science Publishers

Access to resources Recommend Favorite

Second-Line Controller Therapy for Persistent Asthma Uncontrolled on Inhaled Corticosteroids: The Step 3 Dilemma

By Lipworth B.J.  

Drugs, Vol. 62, Iss. 16, 2002-01 ,pp. : 2315-2332

Adis International

Access to resources Recommend Favorite

Role of Leukotrienes and Leukotriene Receptor Antagonists in Asthma

By Jones T.R.   Rodger I.W.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 107-110

Academic Press

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma

By Heaton Pamela C.  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 727-742

Adis International

Access to resources Recommend Favorite